참고문헌
- Berg AT, Kelly MM. Defining intractability: comparisons among published definitions. Epilepsia 2006;47:431-6. https://doi.org/10.1111/j.1528-1167.2006.00440.x
- Shorvon SD. Medical assesment and treatment of chronic epilepsy. BMJ 1991;302:363-6. https://doi.org/10.1136/bmj.302.6773.363
- Vigevano F. Levetiracetam in pediatrics. J Child Neurol 2005; 20:87-93. https://doi.org/10.1177/08830738050200020101
- Glauser TA, Ayala R, Elterman RD, Mitchell WG, Van Orman CB, Glauer LJ, et al. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures. Neurology 2006;66:1654-60. https://doi.org/10.1212/01.wnl.0000217916.00225.3a
- Lynch BA, Lambeng N, Nocka K. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA 2004;101:9861-6. https://doi.org/10.1073/pnas.0308208101
- Vaisleib II, Neft RA. Rapid dosge titration of levetiracetam in children. Pharmacotherapy 2008;28:393-6. https://doi.org/10.1592/phco.28.3.393
- Park JS, Kang HC, You SJ. Clinical experience with levetiracetam adjunctive therapy for pediatric intractable epilepsy. J Korean Child Neurol Soc 2008;16:36-41.
- Radtke RA. Pharmacokinetics of levetiracetam. Epilepsia. 2001;42;24-7.
- Otoul C, Smedt HD, Stockis A. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy. Epilepsia 2007;48:2111-5. https://doi.org/10.1111/j.1528-1167.2007.01201.x
- Glauser TA, Mitchell WG, Weinstock A, Bebin M, Chen D, Coupez R, et al. Pharmacokinetics of levetiracetam in infants and young children with epilepsy. Epilepsia 2007;48:1117- 22. https://doi.org/10.1111/j.1528-1167.2007.01090.x
- Pellock JM, Glauser TA, Bebin EM. Pharmacokinetic study of levetiracetam in children. Epilepsia 2001;42:1574-9.
- Goraya JS, Khurana DS, Valencia I, Melvin JJ, Cruz M, Legido A, et al. Intravenous levetiracetam in children with epilepsy. Pediatr Neurol 2008;38;177-80. https://doi.org/10.1016/j.pediatrneurol.2007.11.003
- Perry MS, Benatar M. Efficacy and tolerability of levetiracetam in children younger than 4 years: A retrospective review. Epilepsia 2007;48:1123-7. https://doi.org/10.1111/j.1528-1167.2007.01003.x
- Pina-Garza JE, Nordli DR, Rating D, Yang H, Jimmy SD, Duncan B, et al. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures. Epilepsia 2009;50:1141-9. https://doi.org/10.1111/j.1528-1167.2008.01981.x
- Coppola G, Mangano S, Tortorella G, Pelliccia A, Fels A, Romano A, et al. Levetiracetam during 1-year follow-up in children, adolescents, and young adults with refractory epilepsy. Epilepsy Res 2004;59:35-42. https://doi.org/10.1016/j.eplepsyres.2004.03.006
- Opp J, Tuxhorn I, May T, Kluger G, Wiemer-Kruel A, Kurlemann G, et al. Levetiracetam in children with refractory epilepsy: A multicenter open label study in Germany. Seizure 2005;14:476-84. https://doi.org/10.1016/j.seizure.2005.08.002
- Grosso S, Cordelli DM, Franzoni E, Coppola G, Capovilla G, Zamponi N, et al. Efficacy and safty of levetiracetam in infants and young children with refractory epilepsy. Seizure 2007;16:345-50. https://doi.org/10.1016/j.seizure.2007.02.004
- Lagae L, Buyse G, Ceulemans B. Clinical experience with levetiracetam in childhood epilepsy: an add-on and monotherapy trial. Seizure 2005;14:66-71. https://doi.org/10.1016/j.seizure.2004.10.004
- Bourgeois BFD, Holder DL, Valencia I. Open-label assesment of levetiracetam efficacy and adverse effects in a pediatric population. Epilepsia 2001;42:53-4.
- Glauser TA, Pellock JM, Bebin EM. Efficacy and safty of levetiracetam in children with partial seizures: An open-lavel trial. Epilepsia 2002;43:518-24. https://doi.org/10.1046/j.1528-1157.2002.13101.x
- Kossoff EH, Los JG, Boatman DF. A pilot study transitioning children onto levetiracetam monotherapy to improve language dysfunction associated with benign rolandic epilepsy. Epilepsy & Behavior 2007;11:514-7. https://doi.org/10.1016/j.yebeh.2007.07.011
- Berkovic SF, Knowlton RC, Leroy RF, Schiemann J, Falter U. Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy. Neurology 2007;69:1751-60.
- Striano P, Coppola A, Pezzella M, Ciampa C, Specchio N, Ragona F, et al. An open-label trial of levetiracetam in severe myoclonic epilepsy of infancy. Neurology 2007;69:250- 4. https://doi.org/10.1212/01.wnl.0000265222.24102.db
- Verrotti A, Cerminara C, Coppola G, Franzoni E, Parisi P, Iannetti P, et al. Levetiracetam in juvenile myoclonic epilepsy: long-term efficacy in newly diagnosed adolescents. Developmental medicine & child neurology 2008;50:29-32.
- Mikati MA, Banna DEI, Sinno D, Mroueh S. Response of infantile spasms to levetiracetam. Neurology 2008;70:574-5. https://doi.org/10.1212/01.wnl.0000279379.32754.8b
- Barron TF, Faircloth VC, Yuncker LA, Hunt SL. Levetiracetam adjunctive therapy for refractory pediatric generalized epilepsies. Epilepsia 2001;42(7 Suppl):S53.
- Buyse G, Ceulemans B, Lagae L. Add-on levetiracetam on refractory generalized childhood epilepsy syndromes. Epilepsia 2002;43(8 Suppl):S154. https://doi.org/10.1046/j.1528-1157.2002.25001.x
- Berg J, Wruk M, Baeumel C, Kluger G, Holthausen H. Addon therapy with levetiracetam in difficult-to-treat, idiopathic focal epilepsies of childhood. Epilepsia 2003;44(8 Suppl):S79. https://doi.org/10.1046/j.1528-1157.44.s6.32.x